Chembio Diagnostics/ US1635722093 /
4/27/2023 10:00:00 PM | Chg. - | Volume | Bid11:38:27 PM | Ask12:05:05 AM | High | Low |
---|---|---|---|---|---|---|
0.4550USD | - | 351,642 Turnover: 104,975.4465 |
0.4300Bid Size: 10,000 | 0.4490Ask Size: 11,300 | 0.4550 | 0.4470 |
GlobeNewswire
8/15/2023
Qualigen Therapeutics, Inc. Reports Financial Results and Corporate Update for Quarter Ending June 3...
GlobeNewswire
3/3/2022
Chembio Diagnostics Reports Fourth Quarter and Full Year 2021 Financial Results
GlobeNewswire
2/17/2022
Chembio Diagnostics to Report Fourth Quarter and Full Year 2021 Financial Results on March 3, 2022
GlobeNewswire
1/6/2022
Chembio Diagnostics Reports Inducement Award Under Nasdaq Listing Rule 5635(c)(4)
GlobeNewswire
1/5/2022
Chembio Diagnostics Announces Appointment of Larry Steenvoorden as Chief Financial Officer
GlobeNewswire
12/6/2021
Chembio Diagnostics Submits FDA De Novo/510(k) Request for DPP SARS-CoV-2 Antigen Test System
GlobeNewswire
11/29/2021
Chembio Diagnostics Receives SAHPRA Approval for DPP SARS-CoV-2 Antigen Test
GlobeNewswire
11/22/2021
Chembio Diagnostic Systems Prevails in International Arbitration Against BioSure (UK) Ltd
GlobeNewswire
11/18/2021
The Benchmark Company Announces Its Upcoming 10th Annual One-on-One Discovery Conference
GlobeNewswire
11/16/2021
Chembio Diagnostics Submits EUA Application for New DPP SARS-CoV-2 Antigen Test
GlobeNewswire
11/15/2021
Chembio Diagnostics Announces Extension of Delivery Schedule for Bio Manguinhos Purchase Order of DP...
GlobeNewswire
10/21/2021
Chembio Diagnostics to Report Third Quarter 2021 Financial Results on November 4, 2021
GlobeNewswire
8/27/2021
Chembio Launches Commercial Distribution of Third-Party COVID-19 Antigen Assay
GlobeNewswire
7/22/2021
Chembio Diagnostics to Report Second Quarter 2021 Financial Results on August 5, 2021
GlobeNewswire
7/22/2021
Chembio Diagnostics Receives $4 Million HIV Test Purchase Order Supported by The Global Fund
GlobeNewswire
7/21/2021
Chembio Diagnostics Receives $28.3 Million Purchase Order from Bio-Manguinhos for DPP SARS-CoV-2 Ant...
GlobeNewswire
4/22/2021
Chembio Diagnostics to Report First Quarter 2021 Financial Results on May 6, 2021
GlobeNewswire
4/1/2021
Chembio Announces U.S. Commercial Launch of Diagnostic Tool to Differentiate COVID-19 and Flu
GlobeNewswire
3/11/2021
Chembio Diagnostics Reports Fourth Quarter and Full Year 2020 Financial Results
GlobeNewswire
3/8/2021
Chembio Diagnostics Appoints Industry Leader David Bespalko to its Board of Directors